Table 2.

Main outcomes

	n (%) or median (range)
Days from operation to administration, day	54 (31–70)
Completion rate, %	25 (54.3%)
Completion rate without recurrence, %	25 (62.5%)
Reson of cessation (n = 21)
Recurrence	6 (28.6%)
Adverse event	13 (61.9%)
Gastrointestinal	8
Myelosuppression	2
Stomatitis	1
Cholangitis	1
Chest pain	1
Others	2 (9.5%)
Traffic accident	1
House-moving	1
Relative dose intensity, %	62.9 (0.7–100)